1.
Percentage of patients with intermediate-thickness (1.2–3.5 mm) melanoma on trunk or limb in Southern Netherlands who underwent SLNB (Sentinel Lymph Node Biopsy).
2.
3.
4.
5.
Survival of patients with intermediate-thickness (1.2–3.5 mm) melanoma on trunk or limb in Southern Netherlands diagnosed 2000–2016 followed up until Feb 2021 by SLNB (Sentinel Lym...
Characteristics of patients with intermediate thickness cutaneous melanoma (1.2–3.5 mm) on trunk or limb (n = 1989) diagnosed 2000–2016 in the Southern Netherlands.
Hazard Ratios (HR) of patients with intermediate-thickness (1.2–3.5 mm) melanoma diagnosed 2010–2016, followed-up until February 2021.
Studies on melanoma comparing outcome of SLNB and excision versus Obs (observation) after excision only.
Additional file 1 of Appropriate medication use in Dutch terminal care: study protocol of a multicentre stepped-wedge cluster randomized controlled trial (the AMUSE study)
Graphical representation of interaction effects in these study.
Overview of participation and drop-out rates.
Overview of subdivisions per CSC for municipality size, implementation strategy and recruitment strategy.
Scores for physical activity behavior, health-related quality of life, motivation, and health-related fitness for drop-outs and remaining participants (means and standard deviation...